INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines

A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) as announced by Pomerantz LLP. The article provides no allegations or financial impact details, but the legal overhang is typically a mild negative for sentiment and may drive incremental risk-off positioning in the stock.